Viewing Study NCT00302757


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2025-12-25 @ 4:11 PM
Study NCT ID: NCT00302757
Status: COMPLETED
Last Update Posted: 2014-05-29
First Post: 2006-03-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma
Sponsor: University Hospital Tuebingen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module